Cargando…
Long‐term efficacy and safety of gonadotropin‐releasing hormone analog treatment in children with idiopathic central precocious puberty: A systematic review and meta‐analysis
OBJECTIVE: To investigate the long‐term efficacy and safety of gonadotropin‐releasing hormone analog (GnRHa) treatment in children with idiopathic central precocious puberty (CPP). METHOD: The protocol was registered with International Prospective Register of Systematic Reviews (CRD42018102792). Pub...
Autores principales: | Luo, Xiaoping, Liang, Yan, Hou, Ling, Wu, Wei, Ying, Yanqin, Ye, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248422/ https://www.ncbi.nlm.nih.gov/pubmed/33387371 http://dx.doi.org/10.1111/cen.14410 |
Ejemplares similares
-
Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
por: Shi, Yuzhen, et al.
Publicado: (2022) -
Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015) -
Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
por: Popovic, Jadranka, et al.
Publicado: (2022) -
Idiopathic central precocious puberty with Prader–Willi syndrome: pubertal development with discontinuation of gonadotropin-releasing hormone analog
por: Kobayashi, Mami, et al.
Publicado: (2022) -
A Case of Nonalcoholic Steatohepatitis in Central Precocious Puberty Aggravated by Gonadotropin-releasing Hormone Analog
por: Sasaki, Yoshiaki, et al.
Publicado: (2020)